Management of multifocal primary cutaneous CD30 + anaplastic large cell lymphoma

Journal of the American Academy of Dermatology

Volumn 51, Issue 1, 2004, Pages 103-110

  Shehan, James M ^a   Kalaaji, Amer N ^a   Markovic, Svetomir N ^a   Ahmed, Iftikhar ^a  

^a MAYO CLINIC   (United States)

Author keywords

ALCL; ALK; anaplastic large cell lymphoma; anaplastic lymphoma kinase; CHOP; cyclophosphamide, Adriamycin, vincristine, prednisone

Indexed keywords

ALPHA INTERFERON; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; BEXAROTENE; BLEOMYCIN; CARBOPLATIN; CD30 ANTIGEN; CD30 MONOCLONAL ANTIBODY; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; ISOTRETINOIN; PREDNISONE; UNCLASSIFIED DRUG; VINCRISTINE;

ADULT; ANAPLASTIC CARCINOMA; ANAPLASTIC LARGE CELL LYMPHOMA; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL FEATURE; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; NEUTROPENIA; PAPULE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RELAPSE; REVIEW; SKIN BIOPSY; SKIN NODULE; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD30; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FATAL OUTCOME; FEMALE; HUMANS; LYMPHOMA, LARGE-CELL, KI-1; NEOPLASM RECURRENCE, LOCAL; PREDNISONE; REMISSION INDUCTION; SKIN NEOPLASMS; STEM CELL TRANSPLANTATION; VINCRISTINE;

EID: 3142609056     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2003.12.028     Document Type: Review

References (27)

1. Willemze R., Beljaards R.C. Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders: a proposal for classification and guidelines for management and treatment. J Am Acad Dermatol. 28:1993;973-980
2. +) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood. 96:2000;3681-3695
3. Jaffe E.S., Harris N.L., Stein H., Vardiman J.W. World Health Organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues. 2001;IARC Press, Lyon, France
4. Fink-Puches R., Zenahlik P., Back B., Smolle J., Kerl H., Cerroni L. Primary cutaneous lymphomas: applicability of current classification schemes (European Organization for Research and Treatment of Cancer, World Health Organization) based on clinicopathologic features observed in a large group of patients. Blood. 99:2002;800-805
5. Zackheim H.S., Vonderheid E.C., Ramsay D.L., LeBoit P.E., Rothfleisch J., Kashani-Sabet M. Relative frequency of various forms of primary cutaneous lymphomas. J Am Acad Dermatol. 43:2000;793-796
6. Harris N.L., Jaffe E.S., Stein H., Banks P.M., Chan J.K., Cleary M.L., et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 84:1994;1361-1392
7. Willemze R., Kerl H., Sterry W., Berti E., Cerroni L., Chimenti S., et al. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood. 90:1997;354-371
8. +): advances in biology and current therapeutic approaches. Clin Lymphoma. 2:2001;29-37
9. Chou W.C., Su I.J., Tien H.F., Liang D.C., Wang C.H., Chang Y.C., et al. Clinicopathologic, cytogenetic, and molecular studies of 13 Chinese patients with Ki-1 anaplastic large cell lymphoma: special emphasis on the tumor response to 13-cis retinoic acid. Cancer. 78:1996;1805-1812
10. Herbst H., Sander C., Tronnier M., Kutzner H., Hugel H., Kaudewitz P. Absence of anaplastic lymphoma kinase (ALK) and Epstein-Barr virus gene products in primary cutaneous anaplastic large cell lymphoma and lymphomatoid papulosis. Br J Dermatol. 137:1997;680-686
11. + cutaneous lymphoproliferative disorders: a clinicopathologic study of 65 cases. Am J Surg Pathol. 22:1998;1192-1202
12. Beljaards R.C., Kaudewitz P., Berti E., Gianotti R., Neumann C., Rosso R., et al. Primary cutaneous CD30-positive large cell lymphoma: definition of a new type of cutaneous lymphoma with a favorable prognosis. A European multicenter study of 47 patients. Cancer. 71:1993;2097-2104
13. de Kan R., van't Veer M.B. Clinical features of CD30 (Ki-1) positive anaplastic large-cell lymphoma (ALCL): review of the literature. Neth J Med. 43:1993;277-284
14. +) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment. Blood. 95:2000;3653-3661
15. Paulli M., Berti E., Rosso R., Boveri E., Kindl S., Klersy C., et al. CD30/Ki-1-positive lymphoproliferative disorders of the skin - clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group. J Clin Oncol. 13:1995;1343-1354
16. Motley R.J., Jasani B., Ford A.M., Poynton C.H., Calonje-Daly J.E., Holt P.J. Regressing atypical histiocytosis, a regressing cutaneous phase of Ki-1-positive anaplastic large cell lymphoma: immunocytochemical, nucleic acid, and cytogenetic studies of a new case in view of current opinion. Cancer. 70:1992;476-483
17. Brice P., Cazals D., Mounier N., Verola O., Neidhart-Berard A.M., Remenieras L., et al., for the Groupe d'Etude des Lymphomes de l'Adulte. rimary cutaneous large-cell lymphoma: analysis of 49 patients included in the LNH87 prospective trial of polychemotherapy for high-grade lymphomas. Leukemia. 12:1998;213-219
18. +) anaplastic large cell lymphomas: morphologic, immunohistologic, and clinical-characteristics. Am J Pathol. 135:1989;359-367
19. Banerjee S.S., Heald J., Harris M. Twelve cases of Ki-1 positive anaplastic large cell lymphoma of skin. J Clin Pathol. 44:1991;119-125
20. Artemi P., Wong D.A., Mann S., Regan W. CD30 (Ki-1)-positive primary cutaneous T-cell lymphoma: report of spontaneous resolution. Australas J Dermatol. 38:1997;206-208
21. French L.E., Shapiro M., Junkins-Hopkins J.M., Vittorio C.C., Rook A.H. Regression of multifocal, skin-restricted, CD30-positive large T-cell lymphoma with interferon alfa and bexarotene therapy. J Am Acad Dermatol. 45:2001;914-918
22. Rijlaarsdam J.U., Huijgens P.C., Beljaards R.C., Bakels V., Willemze R. Oral etoposide in the treatment of cutaneous large-cell lymphomas: a preliminary report of four cases. Br J Dermatol. 127:1992;524-528
23. de Bruin P.C., Beljaards R.C., van Heerde P., Van Der Valk P., Noorduyn L.A., Van Krieken J.H., et al. Differences in clinical behaviour and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T-cell or null cell phenotype. Histopathology. 23:1993;127-135
24. Drews R., Samel A., Kadin M.E. Lymphomatoid papulosis and anaplastic large cell lymphomas of the skin. Semin Cutan Med Surg. 19:2000;109-117
25. Vonderheid E.C., Sajjadian A., Kadin M.E. Methotrexate is effective therapy for lymphomatoid papulosis and other primary cutaneous CD30-positive lymphoproliferative disorders. J Am Acad Dermatol. 34:1996;470-481
26. + tumour cells in vitro and in SCID mice. Br J Haematol. 92:1996;872-879
27. + anaplastic large-cell lymphoma. Blood. 85:1995;2139-2146